The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Namuscla

167 milligram(s) Capsule, hard

Lupin Europe GmbHEU/1/18/1325/001-004

Main Information

Trade NameNamuscla
Active SubstancesMEXILETINE HYDROCHLORIDE
Strength167 milligram(s)
Dosage FormCapsule, hard
Licence HolderLupin Europe GmbH
Licence NumberEU/1/18/1325/001-004

Group Information

ATC CodeC01BB02 mexiletine

Status

Authorised/WithdrawnAuthorised
Licence Issued18/12/2018
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back